SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £203.60m
BVT Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead Vt Share Chart

Interim Management Statement

15 Aug 2014 16:22

RNS Number : 3179P
Baronsmead VCT 2 PLC
15 August 2014
 



Baronsmead VCT 2 plc

 

Interim Management Statement

 

For the 3 month period from 1 April 2014 to 30 June 2014.

 

Headlines

 

· £1.8 million realised from the sale of investments in four quoted companies

 

· £0.4 million invested in 1 new and 3 follow-on investments

 

Performance Summary

 

 

Capital return

As at

30 June 2014

As at

31 March 2014

 

Movement

Total net assets

£86.63m

£86.50m

Net asset value per share

102.56p

102.19p

0.4%

Share price

97.75p

95.75p

2.1%

Discount to NAV

(4.7%)

(6.3%)

Total Return

3 month (%)

1 year (%)

5 year (%)

10 year (%)

Since launch (%)

Net asset value total return (1)

0.4

15.5

 

75.0

 

123.9

217.1

 

Key:

(1) NAV total return = NAV + reinvested dividends; Source: ISIS VC LLP

 

These total returns are stated before the inclusion of VCT tax reliefs which are designed to mitigate the higher risks and costs associated with investing in smaller companies and the constraints of the VCT legislation. The tax reliefs given at the time of subscription have varied between 20% and 40%, so any adjusted performance measure including this relief will vary depending on the date of subscription. There is also the additional ongoing benefit of receiving VCT dividends tax free.

 

 

Investment Performance  

 

In the three months to 30 June 2014, Baronsmead VCT 2's net asset value per share increased by 0.4%. Over the quarter, the unquoted portfolio valuation increased by 1.9%, the quoted portfolio increased by 1.3% and Wood Street Microcap Fund decreased by 4.4%.

 

The Company's net assets as at 30 June 2014 were £86.6 million. This figure takes into account the valuation of the Company's investments as at 30 June 2014.

 

 

Top Ten Investments 

 

Position at 

30 June 2014

Position at 

31 March 2014

 

 Company

Percentage of NAV 

as at 30 June 2014

1

1

Nexus Vehicle Holdings Limited

6.1

2

3

Staffline Group plc

3.5

3

2

Netcall plc

3.4

4

4

IDOX plc

3.2

5

5

Crew Clothing Holdings Limited

2.8

6

7

Valldata Group Limited

2.1

7

14

Accumuli plc

2.0

8

6

Vectura Group plc

1.8

9

8

Independent Community Care Management Limited

1.8

10

12

Create Health Limited

1.8

Total

28.5

 

Analysis of Total Assets

Percentage of total assets at

30 June 2014

Percentage of

total assets at

31 March 2014

Unquoted investments

31

31

AIM, listed, ISDX & collective investment vehicle

46

 

48

Listed interest bearing securities

12

-

Net current assets

11

21

Total liquid assets

23

21

Total assets

100

100

 

 

Analysis of Investment Portfolio by Sector

(excluding cash and interest bearing securities)

 

Percentage of

Total investments at

30 June 2014

Percentage of

 total investments at 

31 March 2014

Business Services

47

46

Consumer Markets

11

12

Healthcare & Education

14

15

Technology, Media & Telecommunications

28

27

Total

100

100

 

 

 

Investment Activity

 

In the three months to 30 June 2014, Baronsmead VCT 2 invested approximately £0.4 million in 1 new and 3 follow on investments as set out in the table below.

 

Investments made

Date

Cost (£'000)

One Media iP Group plc*

Apr 2014

57

Synety Group plc

Apr 2014

113

Happy Days Consultancy Limited*

May 2014

180

Nexus Vehicle Holdings Limited*

May 2014

8

Total investments

358

*Follow on investmentsRealisations

 

In the three months to 30 June 2014, Baronsmead VCT 2 realised total proceeds of £1.8 million from the sale of four quoted investments. Details are set out in the table below.

 

 

Realisations

Company

Date

Cost

(£'000)

Proceeds

(£'000)

Multiple

 

Anpario plc

Apr/Jun 2014

69

284

4.1

Sinclair IS Pharma plc

May 2014

524

546

1.0

Murgitroyd Group plc

May/Jun 2014

130

707

5.4

Tristel plc

Jun 2014

217

281

1.3

Total realisations

940

1,818

 

 

Dividend

 

Following an exceptional period of divestments, an interim dividend of 6p per share was paid on 7 March 2014. In the absence of unforeseen circumstances, it is anticipated that a second interim dividend will be paid in September 2014.

 

Net Asset Value as at 31 July 2014

 

The net asset value as at 31 July 2014 was 102.82p per share.

 

Investment objective

 

Baronsmead VCT 2 is a tax efficient listed company which aims to achieve long-term investment returns for private investors, including tax free dividends.

 

 

Events after the period end

 

Other than the events described above, the Board is not aware of any significant events or transactions which have occurred between 30 June 2014 and the date of publication of this statement which would have a material impact on the financial position of the Company.

 

 

Further information 

 

Further information regarding the Company, including net asset values published since the end of the period and quarterly factsheets, can be found at the Company's website www.baronsmeadvct2.co.uk

 

 

Contact

 

For further information please contact the Company's Investment Manager, ISIS VC LLP as follows:

Email: baronsmeadvcts@isisep.com

Telephone: 020 7506 5717

Facsimile: 020 7506 5718

Post: 100 Wood Street, London, EC2V 7AN

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUGPRUPCGAA
Date   Source Headline
6th Dec 20183:30 pmRNSNet Asset Value(s)
3rd Dec 20183:40 pmRNSTotal Voting Rights
3rd Dec 20187:00 amRNSChange of Registered Office
27th Nov 20185:59 pmRNSTransaction in Own Shares
23rd Nov 201811:29 amRNSAnnual Financial Report - Replacement
23rd Nov 20187:00 amRNSAnnual Financial Report
8th Nov 20185:06 pmRNSChange in management arrangements
6th Nov 20186:05 pmRNSNet Asset Value(s)
15th Oct 201812:15 pmRNSNet Asset Value(s)
1st Oct 201812:16 pmRNSTotal Voting Rights
27th Sep 20185:31 pmRNSTransaction in Own Shares
6th Sep 20184:00 pmRNSNet Asset Value(s)
9th Aug 20184:15 pmRNSIntention to Fundraise
9th Aug 20184:15 pmRNSDividend Declaration
7th Aug 201810:00 amRNSNet Asset Value(s)
13th Jul 20182:00 pmRNSNet Asset Value(s)
11th Jul 201812:27 pmRNSDirector Declaration
2nd Jul 20184:22 pmRNSTotal Voting Rights
28th Jun 20185:00 pmRNSTransaction in Own Shares
6th Jun 20184:30 pmRNSNet Asset Value(s)
1st Jun 201811:20 amRNSTotal Voting Rights
30th May 201811:38 amRNSTransaction in Own Shares
25th May 20187:00 amRNSHalf-year Report
14th May 20182:20 pmRNSDirector Declaration
4th May 20184:30 pmRNSNet Asset Value(s)
12th Apr 20183:00 pmRNSNet Asset Value(s)
3rd Apr 20181:02 pmRNSTotal Voting Rights
28th Mar 20185:39 pmRNSTransaction in Own Shares
6th Mar 20184:00 pmRNSNet Asset Value(s)
21st Feb 20183:15 pmRNSResult of AGM
7th Feb 201810:00 amRNSNet Asset Value(s)
18th Jan 201812:30 pmRNSNet Asset Value(s)
17th Jan 20183:30 pmRNSDirectorate Change
2nd Jan 20185:46 pmRNSTotal Voting Rights
20th Dec 20175:35 pmRNSTransaction in Own Shares
7th Dec 20172:30 pmRNSNet Asset Value(s)
5th Dec 20172:41 pmRNSDirectorate Change
1st Dec 201710:30 amRNSTotal Voting Rights
29th Nov 20175:29 pmRNSPublication of a supplementary prospectus
21st Nov 20176:00 pmRNSTransaction in Own Shares
21st Nov 20177:00 amRNSAnnual Financial Report
10th Nov 20174:15 pmRNSIssue of New Shares
7th Nov 20175:00 pmRNSNet Asset Value(s)
6th Nov 201711:15 amRNSOffer for Subscription - Update
1st Nov 20175:34 pmRNSDirector/PDMR Shareholding
1st Nov 20171:15 pmRNSTotal Voting Rights
26th Oct 20174:30 pmRNSIssue of New Shares
11th Oct 20175:30 pmRNSNet Asset Value(s)
4th Oct 20175:03 pmRNSPublication of a Prospectus - Replacement
4th Oct 20174:30 pmRNSPublication of a Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.